Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema | Zendy

Andrea Russo | Zendy; Ciro Costagliola | Zendy; Luisa Delcassi | Zendy; Francesco Parmeggiani | Zendy; Mario R. Romano | Zendy; Roberto dell’Omo | Zendy; Francesco Semeraro | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema

Author(s) -

Andrea Russo,

Ciro Costagliola,

Luisa Delcassi,

Francesco Parmeggiani,

Mario R. Romano,

Roberto dell’Omo,

Francesco Semeraro

Publication year - 2013

Publication title -

mediators of inflammation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.37

H-Index - 97

eISSN - 1466-1861

pISSN - 0962-9351

DOI - 10.1155/2013/476525

Subject(s) - medicine , macular edema , nonsteroidal , macular degeneration , maculopathy , drug , ophthalmology , edema , anti inflammatory , inflammation , antiinflammatory drug , retinal , pharmacology , surgery , diabetes mellitus , retinopathy , endocrinology

Nonsteroidal anti-inflammatory drugs (NSAIDs) are nowadays widely used in ophthalmology to reduce eye inflammation, pain, and cystoid macular edema associated with cataract surgery. Recently, new topical NSAIDs have been approved for topical ophthalmic use, allowing for greater drug penetration into the vitreous. Hence, new therapeutic effects can be achieved, such as reduction of exudation secondary to age-related macular degeneration or diabetic maculopathy. We provide an updated review on the clinical use of NSAIDs for retinal diseases, with a focus on the potential future applications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research